Masimo (NASDAQ:MASI – Get Free Report) is set to issue its quarterly earnings data after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $0.71 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.
Masimo (NASDAQ:MASI – Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The medical equipment provider reported $1.25 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.43. Masimo had a net margin of 3.98% and a return on equity of 13.77%. The firm had revenue of $548.90 million for the quarter, compared to analyst estimates of $545.69 million. During the same quarter in the prior year, the firm earned $1.32 EPS. The company’s revenue was down 11.0% on a year-over-year basis. On average, analysts expect Masimo to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Masimo Price Performance
Shares of MASI traded up $0.38 during mid-day trading on Tuesday, hitting $136.58. 88,721 shares of the company traded hands, compared to its average volume of 549,429. The company has a current ratio of 2.18, a quick ratio of 1.22 and a debt-to-equity ratio of 0.64. The stock has a market capitalization of $7.23 billion, a price-to-earnings ratio of 90.20 and a beta of 0.97. The business has a 50-day moving average of $135.80 and a 200 day moving average of $117.18. Masimo has a one year low of $75.22 and a one year high of $190.82.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Report on Masimo
Masimo Company Profile
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.
Further Reading
- Five stocks we like better than Masimo
- EV Stocks and How to Profit from Them
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the Dow Jones Industrial Average (DJIA)?
- Hilton Demonstrates Asset Light is Right for Investors
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.